These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 2269307)

  • 1. Expression of human liver cytochrome P450 IIIA4 in yeast. A functional model for the hepatic enzyme.
    Renaud JP; Cullin C; Pompon D; Beaune P; Mansuy D
    Eur J Biochem; 1990 Dec; 194(3):889-96. PubMed ID: 2269307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of yeast-expressed human liver cytochrome P450 3A4 catalytic activities by coexpressing NADPH-cytochrome P450 reductase and cytochrome b5.
    Peyronneau MA; Renaud JP; Truan G; Urban P; Pompon D; Mansuy D
    Eur J Biochem; 1992 Jul; 207(1):109-16. PubMed ID: 1628642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiae.
    Brian WR; Sari MA; Iwasaki M; Shimada T; Kaminsky LS; Guengerich FP
    Biochemistry; 1990 Dec; 29(51):11280-92. PubMed ID: 2271712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
    Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
    Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant yeast in drug metabolism.
    Renaud JP; Peyronneau MA; Urban P; Truan G; Cullin C; Pompon D; Beaune P; Mansuy D
    Toxicology; 1993 Oct; 82(1-3):39-52. PubMed ID: 8236280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High affinity of ergopeptides for cytochromes P450 3A. Importance of their peptide moiety for P450 recognition and hydroxylation of bromocriptine.
    Peyronneau MA; Delaforge M; Riviere R; Renaud JP; Mansuy D
    Eur J Biochem; 1994 Aug; 223(3):947-56. PubMed ID: 8055971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactivation of aflatoxin B1 by human liver microsomes: role of cytochrome P450 IIIA enzymes.
    Ramsdell HS; Parkinson A; Eddy AC; Eaton DL
    Toxicol Appl Pharmacol; 1991 May; 108(3):436-47. PubMed ID: 1902334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic activities of human debrisoquine 4-hydroxylase cytochrome P450 (CYP2D6) expressed in yeast.
    Ellis SW; Ching MS; Watson PF; Henderson CJ; Simula AP; Lennard MS; Tucker GT; Woods HF
    Biochem Pharmacol; 1992 Aug; 44(4):617-20. PubMed ID: 1510710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression in yeast of three allelic cDNAs coding for human liver P-450 3A4. Different stabilities, binding properties and catalytic activities of the yeast-produced enzymes.
    Peyronneau MA; Renaud JP; Jaouen M; Urban P; Cullin C; Pompon D; Mansuy D
    Eur J Biochem; 1993 Dec; 218(2):355-61. PubMed ID: 8269924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of specifically active recombinant fused enzymes consisting of CYP3A4, NADPH-cytochrome P450 oxidoreductase, and cytochrome b5.
    Inui H; Maeda A; Ohkawa H
    Biochemistry; 2007 Sep; 46(35):10213-21. PubMed ID: 17691855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of mRNA species related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity.
    Bork RW; Muto T; Beaune PH; Srivastava PK; Lloyd RS; Guengerich FP
    J Biol Chem; 1989 Jan; 264(2):910-9. PubMed ID: 2463251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P-450 related to P-4504 from phenobarbital-treated rabbit liver: molecular cloning of cDNA and characterization of cytochrome P-450 obtained by its expression in yeast cells.
    Imai Y
    J Biochem; 1987 May; 101(5):1129-39. PubMed ID: 2820951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 IIIA4.
    Guengerich FP; Brian WR; Iwasaki M; Sari MA; Bäärnhielm C; Berntsson P
    J Med Chem; 1991 Jun; 34(6):1838-44. PubMed ID: 2061924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of erythromycin and roxithromycin on oxidation of testosterone and nifedipine catalyzed by CYP3A4 in human liver microsomes.
    Yamazaki H; Urano T; Hiroki S; Shimada T
    J Toxicol Sci; 1996 Nov; 21(4):215-26. PubMed ID: 8959645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae.
    Brian WR; Srivastava PK; Umbenhauer DR; Lloyd RS; Guengerich FP
    Biochemistry; 1989 Jun; 28(12):4993-9. PubMed ID: 2669966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of rabbit liver P450IIE1 synthesized in transformed yeast cells.
    Imai Y; Uno T; Nakamura M
    J Biochem; 1990 Oct; 108(4):522-4. PubMed ID: 2292581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes.
    Iribarne C; Berthou F; Baird S; Dréano Y; Picart D; Bail JP; Beaune P; Ménez JF
    Chem Res Toxicol; 1996 Mar; 9(2):365-73. PubMed ID: 8839037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans.
    Shimada T; Mimura M; Inoue K; Nakamura S; Oda H; Ohmori S; Yamazaki H
    Arch Toxicol; 1997; 71(6):401-8. PubMed ID: 9195021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism.
    Guengerich FP; Martin MV; Beaune PH; Kremers P; Wolff T; Waxman DJ
    J Biol Chem; 1986 Apr; 261(11):5051-60. PubMed ID: 3514607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexpression of genetically engineered fused enzyme between yeast NADPH-P450 reductase and human cytochrome P450 3A4 and human cytochrome b5 in yeast.
    Hayashi K; Sakaki T; Kominami S; Inouye K; Yabusaki Y
    Arch Biochem Biophys; 2000 Sep; 381(1):164-70. PubMed ID: 11019832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.